Clinical trial
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery
NCT01690715 is registered in ClinicalTrials.gov with Hospital Sirio-Libanes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery
- Lead sponsor
- Hospital Sirio-Libanes
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 31, 2012
- Completion date
- August 30, 2012
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatic portal vein tumor invasion, hepatocellular carcinoma, portal vein thrombosis